| 23rd week of 2015 patent applcation highlights part 19 |
| Patent application number | Title | Published |
|---|
| 20150151990 | TRANSPORTATION OF FLOCCULATED TAILINGS IN A PIPELINE - A method for transporting flocculated tailings through a pipeline is provided comprising: adding an effective amount of a flocculant or a coagulant or a combination thereof to the mining tailings to form treated mining tailings comprising tailings flocs and release water; and injecting the treated mining tailings into the pipeline at a shear rate sufficient to form a self-lubricated core-annular flow of the treated mining tailings; whereby the release water forms a protective layer around the pipeline walls thereby reducing shearing of the tailings flocs. | 2015-06-04 |
| 20150151991 | NEUTRALIZATION METHOD - A method for reducing usage amount of expensive high alkaline neutralizer, and applying efficient neutralization treatment, when applying a neutralization treatment to a barren solution to produce in a treatment step, in which a sulfide compose of nickel and cobalt is produced from a sulfuric acid aqueous solution containing nickel and cobalt, and impurity metals containing at least one or more of iron, magnesium, and manganese. A first neutralization treatment step of applying a neutralization treatment to the barren solution, with a range of pH 5.0 to 6.0 as the end point, by using calcium carbonate slurry, as a first neutralizer; and a second neutralization treatment step of applying a neutralization treatment to a solution produced in the first neutralization treatment step, by using a second neutralizer, to produce sediment containing metal remained in the barren solution and a post-neutralization solution from which a metal ion is removed. | 2015-06-04 |
| 20150151992 | METHOD AND SYSTEM FOR PROVIDING PURIFIED WATER - A method of providing at least two outlet purified water streams from a water purification system by providing a first purified water into a first reservoir able to provide an outlet purified water stream. At least a portion of the first purified water is passed from the first reservoir through a water purification process to provide an ultra-purified water stream. The ultra-purified water stream is passed to a second reservoir. An excess of ultra-purified water is provided into the second reservoir beyond a pre-determined quantity, The excess ultra-purified water in the second reservoir is allowed to flow from the second reservoir into the first reservoir. An outlet from the water purification system of an ultra-purified water stream is provided from the second reservoir. | 2015-06-04 |
| 20150151993 | Enhanced Reactive Zone - Disclosed is a new form of reactive ozone and techniques for producing nanobubble suspensions of the reactive ozone. The bubbles entrap a high concentration of ozone, with the ozone orienting a net negative charge outwards and a net positive charge inwards. | 2015-06-04 |
| 20150151994 | SINGLE-TANK NUTRIENT REMOVAL SYSTEM USING IMMOBILIZED BIOMASS - A method and system are provided for treating water, such as wastewater, landfill leachate, or contaminated groundwater. A single tank is used. A structure with a unique design within the tank promotes growth of immobilized biomass. A recycle stream transports some of the fluid output from near the top of the tank back to the bottom of the tank, the rest of the fluid output leaving the water treatment system as effluent. Oxygenation means within the tank cause fluid to flow upwards, and this together with the recycle stream causes fluid to circulate through the immobilized biomass. The oxygenation means result in the formation of an aerobic zone, and the location and/or aeration flow rate of the oxygenation means result in an oxygen-depleted zone. Different processes occur in the aerobic and oxygen-depleted zones, removing a variety of contaminants. The use of a recycle stream and of immobilized biomass results in efficient water treatment, even though a single tank is used, and the water treatment system can have a low footprint and cost. | 2015-06-04 |
| 20150151995 | Water Treatment System and Method for Removal of Contaminants Using Biological Systems - A novel biologically active water treatment system for removing contaminant from industrial effluent and method thereof is provided. A novel upflow bioreactor system having an expanded bed configuration and method for creating an expanded bed for release of gas without release of substantial precipitate is also provided. A novel downflow bioreactor system having an automated degas and backwash system is also provided. | 2015-06-04 |
| 20150151996 | Self-Regenerating Zeolite Reactor for Sustainable Ammonium Removal - A method of using micro-organisms to continuously and sustainably regenerate zeolite cation exchange capacity (CEC) for removing nitrogen (ammonium, nitrite, and nitrate) from wastewater. The zeolite immobilizes the ammonium ions, and the micro-organisms ingest the ammonium from the surface of the zeolite thereby freeing the cation exchange sites to trap more ammonium. The zeolite is continuously regenerated by the microbes, sustainably maintaining available ion exchange capacity for removing ammonium, and does not need to be shut down for regeneration or replacement. The microbial complex contains nitrifiers, anammox, denitrifiers, archaea, and others. All the micro-organisms co-exist in the same reactor promoting symbiotic interactions, thereby increasing treatment efficiency. The end product is di-nitrogen gas which dissipates into the atmosphere. The system does not require aeration, operates by gravity flow, and has very low energy requirements. Maintenance is minimal, and the system can significantly reduce greenhouse gas emissions (nitrous oxide). | 2015-06-04 |
| 20150151997 | PROCESSES FOR THE BIODEGRADATION OF NDMA - NDMA can be degraded by | 2015-06-04 |
| 20150151998 | Water Reclamation Apparatus and Method of Operation - A water reclamation system is composed of a high-capacity input pump connected to an ionizer, which dissociates solid or biological particles from the water. After leaving the ionizer, the fluid stream is run through staged filter systems progressively filtering the solids from the water, which is then fed to a reverse osmosis system for further filtration. Rejected water is diverted to a series of thermal units which cause the rejected water to flash into steam which is returned to the cleaned water stream of the reverse osmosis unit for discharge or further use; the remaining water, having the remaining solids and biological materials, is sent to a fracture unit where it is incinerated at an elevated temperature. The system is designed to provide parallel backups at each part of the process allowing cleaning to take place continuously while the other parallel system is operating. | 2015-06-04 |
| 20150151999 | SLUDGE TREATMENT METHOD - The present invention relates to the treatment of sludge and, more particularly, to a method for recovering phosphate as a substantially solid component from a phosphate-containing sludge. Some embodiments of the invention relate to a method for recovering phosphate as a substantially solid component and aluminium as a liquid component from a phosphate-containing and aluminium-containing sludge. The method incorporates wet oxidation to decompose the organic components of the sludge to provide a residual sludge. The residual sludge comprises the insoluble components and, in some embodiments wherein the sludge comprises aluminium, the residual sludge further comprises suspended and/or soluble aluminium. | 2015-06-04 |
| 20150152000 | SLUDGE DRYING SYSTEM - Disclosed therein is a sludge drying system which dries organic sludge generated in industrial sites or domestic sewage treatment plants by mixing the sludge with heat transfer oil, thereby contributing to improvement of drying efficiency. The sludge drying system includes: a preprocessing part including a sludge supplying part, a transfer oil storage tank, a recoverable oil storage tank, and a preheating and mixing tank; a drying part including first to fourth drying parts respectively having first to fourth vacuum drying pipes, and first to fourth liquid-vapor separators and first to fourth condensers, and a controlling part having first and second vacuum drying control pipes, fifth and sixth liquid-vapor separators and fifth and sixth condensers; and a post-processing part having a feeding tank, a centrifugal oil extractor, and a dried sludge storage tank. | 2015-06-04 |
| 20150152001 | DEVICE FOR FLOWING MOLTEN GLASS - A device for flowing molten glass suitable for installation on a glass melting furnace, including: a flow channel including an outlet of given diameter; and a device for regulating flow of molten glass at an outlet of the flow channel, including: a removable plate including a through-orifice with an area smaller than an area of the outlet of the flow channel; and a movable shuttering mechanism configured to adjustably shutter the outlet of the flow channel or the through-orifice of the removable plate. The device allows a single furnace to be used for various types of glasses having very different viscosities. | 2015-06-04 |
| 20150152002 | BENDING DEVICE FOR SHAPING GLASS FOR USE IN AIRCRAFT TRANSPARENCIES - A glass sheet used in the making of an aircraft windshield is shaped using the “cut-to-size” method instead of the “cut-after-bend” method. In a preferred aspect of the invention the “cut-to-size” method is practiced using a bending iron having a sheet shaping rail having a stationary shaping rail portion mounted on a support member and an articulating shaping rail portion pivotally mounted on the support member for movement from a non-shaping position to a shaping position. | 2015-06-04 |
| 20150152003 | REINFORCED GLASS, REINFORCED GLASS PLATE, AND GLASS TO BE REINFORCED - A tempered glass is a tempered glass having a compression stress layer in a surface thereof, comprising as a glass composition, in terms of mol %, 50 to 80% of SiO | 2015-06-04 |
| 20150152004 | GLASS SHEET/FLUORORESIN LAMINATE - To provide a laminate which is thin and light in weight, which has excellent gas barrier properties, flexibility and durability, and which is excellent in the flatness. A glass sheet/fluororesin laminate comprising a glass sheet having a thickness of from 10 to 500 μm, and a fluororesin coated layer preferably having a thickness of from 0.1 to 1,000 μm. Particularly, the thickness ratio of the fluororesin coated layer to the glass sheet is preferably from 0.001 to 10 by the fluororesin coated layer/the glass sheet. Further, the transmittance at a wavelength of from 400 to 700 nm is preferably at least 80%. Further, this laminate is suitable as a protective plate. Still further, this laminate is suitably applied to a photoelectric conversion element. | 2015-06-04 |
| 20150152005 | LIGHTWEIGHT SYNTHETIC PARTICLE AND METHOD OF MANUFACTURING SAME - Lightweight synthetic particles that replace traditional aggregates and methods of producing the same are disclosed herein. | 2015-06-04 |
| 20150152006 | CONCRETE COMPOSITIONS WITH REDUCED DRYING TIME AND METHODS OF MANUFACTURING SAME - Cementitious compositions and methods for preparing and using the cementitious compositions to yield hardened concrete. The cementitious compositions yield hardened concrete having reduced or attenuated water vapor emission and lower internal relative humidity (IRH). Cementitious compositions are characterized by the property of rapid surface drying while maintaining good workability, particularly when using porous lightweight aggregates that absorb substantial amounts of water. Methods of decreasing water availability and increasing surface drying of concrete, including lightweight concrete, are provided. A water soluble ionic salt may be used to sequester water within the pores and capillaries of the cement paste and/or porous lightweight aggreate by modifying the colligative propertie of pore water. The salt may be added directly to concrete or the concrete mix water, or, alternatively, aggregates may be infused with a water-salt solution to provide treated porous aggregates having improved water saturation and water retention. | 2015-06-04 |
| 20150152007 | POLYCARBOXYLIC COPOLYMER, CEMENT DISPERSION AGENT, CEMENT ADMIXTURE, AND CEMENT COMPOSITION - The present invention aims to provide a polycarboxylic acid copolymer which is excellent in various properties, in particular dispersibility, and is useful in various uses such as dispersants and admixtures for cement. The present invention also aims to provide a dispersant for cement, an admixture for cement, and a cement composition each containing the above polycarboxylic acid copolymer. The polycarboxylic acid copolymer of the present invention includes a structural unit (I) derived from an unsaturated polyalkylene glycol monomer (a) and a structural unit (II) derived from an unsaturated carboxylic acid monomer (b). The copolymer has a weight average molecular weight (Mw) of 5000 to 25000. The copolymer includes a dimer including two units of the unsaturated polyalkylene glycol monomer (a) bonded to each other, and has an area percentage of the dimer of 7% or higher. | 2015-06-04 |
| 20150152008 | PULVERULENT ACCELERATOR - The invention concerns a solid composition comprising calcium silicate hydrate and at least one water-soluble cationic (co)polymer. Additionally, a process for producing the compositions, in which an aqueous suspension of calcium silicate hydrate, preferably suitable as a setting and curing accelerator for (portland)cement-containing binder systems, is contacted with at least one cationic (co)polymer and the product is dried. Also concerned is the use as setting accelerator in preferably (portland)cement-containing building material mixtures and as grinding assistant in the production of (portland) cement. The invention further concerned building material mixtures comprising the solid compositions of the invention. | 2015-06-04 |
| 20150152009 | HYDRAULIC BINDER COMPOSITION USING RAPIDLY-COOLED STEELMAKING REDUCED SLAG POWDER, AND METHOD OF PREPARING THE SAME - Disclosed are a hydraulic binder composition using rapidly-cooled steelmaking reduced slag powder and a method of preparing the same. More particularly, the rapidly-cooled steelmaking reduced slag (RC-LFS) powder is obtained by spraying and scattering gas at a high pressure and high speed onto electric furnace smelting reduction slag, which is one of the by-products generated during iron smelting performed in an ironworks, and quickly cooling and pulverizing the slag. The initial high hydration heat reaction and initial setting of the rapidly-cooled steelmaking reduced slag (RC-LFS) powder are delayed to ensure workability. A retardant and gypsum are mixed into the rapidly-cooled steelmaking reduced slag (RC-LFS) powder so as to activate the generation of needle-shaped ettringite and to thus develop the initial and long-term strength, and therefore the rapidly-cooled steelmaking reduced slag (RC-LFS) powder of the present invention can be used as a substitute for ordinary Portland cement. | 2015-06-04 |
| 20150152010 | METHOD FOR STABILIZING BETA-HEMIHYDRATE PLASTER - The instant invention is concerned with the post-treatment of β-hemihydrate plasters for the purpose of stabilization. The invention relies in the addition of a retardant to the calcined β-hemihydrate. It is also the purpose of the invention to provide stabilized β-hemihydrate plasters which exhibit advantageous properties. | 2015-06-04 |
| 20150152011 | HYDROPHOBIC LOW SHRINKAGE LIGHTWEIGHT CEMENTITIOUS MATRIX - The present invention provides a composition for forming a lightweight, low shrinkage and hydrophobic cementitious matrix, and a method for preparing thereof. The present cementitious matrix formed by the composition is lightweight, hydrophobic (or water repelling) and with low shrinkage which is useful in building and construction industry as non-structural wall resistant to water, heat and sound entry. The present invention also provides a method of preparing the composition and the cementitious matrix formed from the composition. | 2015-06-04 |
| 20150152012 | PRODUCT MADE FROM SILICON CARBIDE FOR SHIELDING - A product obtained by solid-phase sintering of a silicon carbide powder and of a sintering additive, the product having a relative density of greater than 98.5% and including: more than 92% by weight of SiC present in the form of grains, less than 2% by weight of elemental oxygen, less than 6% by weight, in total, of other elements, wherein more than 10% by number of the SiC grains, on the basis of the total number of the grains, have all elongation factor F of greater than 3 (F>3), wherein more than 50% by number of the grains, the elongation factor F of which is greater than 3, have a width of greater than 3 micrometers, and wherein the other SiC grains in the product have a mean equivalent diameter of greater than 1 micrometer and less than 20 micrometers. | 2015-06-04 |
| 20150152013 | METAMATERIAL AND MANUFACTURING METHOD THEREOF - A manufacturing method of a metamaterial having a spatial geometric structure includes: step 1, making a first dielectric enclosure having a spatial geometric shape; step 2, making a dielectric patch having at least one conductive geometric structure; step 3, attaching at least one dielectric patch to a part or all of a surface of the first dielectric enclosure, so that the dielectric patches are spliced together to form at least one dielectric patch layer having the spatial geometric shape; and step 4, combining the first dielectric enclosure and the dielectric patch layer together. | 2015-06-04 |
| 20150152014 | SELF-SETTING CEMENT FOAM - The invention relates to a self-setting porous cement foam ( | 2015-06-04 |
| 20150152015 | CONTINUOUS PROCESS FOR MANUFACTURING A NEUTRAL GRANULAR P/K FERTILIZER - The invention provides a continuous process for manufacturing an essentially neutral phosphorus/potassium rich fertilizer from basic chemical commodities. The fertilizer is a freely-flowing particulate solid. | 2015-06-04 |
| 20150152016 | AGRICULTURAL BLEND, AGRICULTURAL BINDER SYSTEM, AND PROCESS OF FORMING AN AGRICULTURAL BLEND - An agricultural blend, an agricultural binder system, and a process of forming an agricultural blend are described. The agricultural blend includes a binder system having soy polymer and one or both of metal slag by-product and synthetic gypsum. The agricultural binder system includes soy polymer. The agricultural binder system is a powder. The process of forming an agricultural blend includes blending a binder system having soy polymer with one or both of metal slag by-product and synthetic gypsum to form the agricultural blend. | 2015-06-04 |
| 20150152017 | WATER-DISPERSIBLE PARTICLES FORMED WITH GRANULES EMBEDDED IN CRYSTALLIZED MATRIX - A water-dispersible particle is provided that has a crystalline matrix formed of a potassium salt, a phosphate salt, of a combination thereof. Embedded in the matrix are at least 100 insoluble granules of at least one macronutrient or micronutrient. The granules, and the matrix present in a form such that contact with water causes particle dispersion into more than 100 pieces in a time period of up to 1 hour. A process of forming a fertilizer particle includes the granulation of a quantity of insoluble material to a size where the majority by weight is between 0.02 and 3 millimeters to from granules. The granules are agglomerated into the fertilizer particle containing at least 100 of the granules with a solution of a potassium salt, a phosphate salt, of a combination thereof through solvent removal to form the crystalline matrix in which the granules are embedded. | 2015-06-04 |
| 20150152018 | SOLVENT-FREE PROCESSING, SYSTEM AND METHODS - Disclosed is a process for purifying one or more chemical constituents from plant matter using extraction with a fluid that is not a solvent, for example, with a vegetable oil. The extracted chemical constituents may then optionally be further processed by heating in order to induce desired chemical transformations. The extracted chemical constituents are also processed by concentrating at reduced pressure, for example, by distillation. | 2015-06-04 |
| 20150152019 | PROCESS FOR CONVERSION OF NATURAL GAS TO HYDROCARBON PRODUCTS AND A PLANT FOR CARRYING OUT THE PROCESS - A process for the conversion of natural gas to hydrocarbon products comprises the steps of (a) mixing natural gas with a small amount of hydrogen, (b) purifying the mixture from (a) in a feed purification section to obtain purified natural gas, (c) mixing the purified natural gas from (b) with steam to obtain the desired steam-to-carbon (S/C) ratio, (d) mixing the natural gas/steam mixture from (c) with the tail gas from the downstream Fischer-Tropsch synthesis or a part thereof in a syngas section and converting the mixture into a synthesis gas, (e) cooling the synthesis gas from (d) and condensing out the process water from it, (f) leading the dry synthesis gas from (e) to a carbon dioxide removal section, where the CO | 2015-06-04 |
| 20150152020 | Process to Make Olefins from Oxygenates - The present invention relates to a process to make light olefins, in a combined XTO-OC process, from an oxygen-containing, halogenide-containing or sulphur-containing organic feedstock comprising: | 2015-06-04 |
| 20150152021 | PROCESS TO MAKE OLEFINS AND AROMATICS FROM ORGANICS - The present invention relates to a process to make light olefins and aromatics, in a combined XTO-OC process, from an oxygen-containing, halogenide-containing or sulphur-containing organic feedstock comprising:
| 2015-06-04 |
| 20150152022 | CARBON NANOHOOPS AND METHODS OF MAKING - The present invention provides cycloparaphenylene compounds, their macrocyclic precursors, and methods for making the compounds. The cycloparaphenylene compounds can be used to prepare armchair carbon nanotubes. | 2015-06-04 |
| 20150152023 | Isononylamines from 2-Ethylhexanol, Processes for Their Preparation, and Their Use - Process for preparing isononylamines starting out from 2-ethylhexanol, characterized in that (a) 2-ethylhexanol is dehydrated in the presence of a catalyst to form octene; (b) the octene obtained in step a) is reacted with carbon monoxide and hydrogen in the presence of a transition metal compound of group VIII of the Periodic Table of the Elements to form isononanal; and (c) the isononanal obtained in step b) is converted into isononylamines. | 2015-06-04 |
| 20150152024 | METHOD FOR CONVERTING OLEFIN OR ALCOHOL AND METHOD FOR PRODUCING PROPYLENE OR AROMATIC COMPOUND - A method for converting an olefin or an alcohol has a pretreatment step of obtaining a conductive catalyst by a pretreatment for suppressing electrostatic charging of a non-conductive catalyst and a step of converting an olefin or an alcohol by a fluidized bed reaction using the conductive catalyst. | 2015-06-04 |
| 20150152025 | REACTORS AND SYSTEMS FOR OXIDATIVE COUPLING OF METHANE - In an aspect, the present disclosure provides a method for the oxidative coupling of methane to generate hydrocarbon compounds containing at least two carbon atoms (C | 2015-06-04 |
| 20150152026 | Reactors and Processes for the Oxidative Coupling of Hydrocarbons - A method for the oxidative coupling of hydrocarbons includes providing an oxidative catalyst inside a reactor and carrying out the oxidative coupling reaction under a set of reaction conditions. The reactor surfaces that contact the reactants and products do not provide a significant detrimental catalyzing effect. In an embodiment the reactor contains an inert lining or a portion of the reactor inner surface is treated to reduce the detrimental catalytic effects. In an embodiment the reactor contains a lining that includes an oxidative catalyst. | 2015-06-04 |
| 20150152027 | INTEGRATED SOLVENT-DEASPHALTING AND FLUID CATALYTIC CRACKING PROCESS FOR LIGHT OLEFIN PRODUCTION - The process described herein broadly comprehends an integrated process that permits the use of straight run residual fractions as a feedstock to produce lighter olefins including propylene. A blend of natural gas condensate and/or naphtha, and heavy oil residue(s), is catalytically cracked to produce a light olefin-rich product stream. In particular, the light natural gas condensate and/or naphtha stream is used as both solvent in a solvent-deasphalting unit and a portion for the feedstock to a fluidized catalytic cracking process. In addition, blending a heavy boiling hydrocarbon stream with a light natural gas condensate or naphtha stream enables efficient cracking in fluidized catalytic cracking process processes while sustaining the heat balance within the cracking unit. | 2015-06-04 |
| 20150152028 | METHOD FOR PROLONGING A CATALYST'S LIFE DURING HYDROFLUORINATION - The invention provides an improved process to manufacture 2-chloro-1,1,1,2-tetrafluoropropane (HCFC-244bb) by reacting 2-chloro-3,3,3,-trifluoropropene (HCFO-1233xf) with hydrogen fluoride, in the presence of a fluorination catalyst, where by using 2-chloro-3,3,3,-trifluoropropene (HCFO-1233xf) of high purity, the need to add an oxidizing agent (typically chlorine) to keep the catalyst active can be avoided. The HCFC-244bb is then used as an intermediate in the production of 2,3,3,3-tetrafluoropropene-1 (HFO-1234yf). | 2015-06-04 |
| 20150152029 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS - The chemoselective reduction of a carboxylic ester (I) to an alcohol by catalytic hydrogenation, in particular in the presence of a transition metal complex, more particularly in the presence of a ruthenium (II) complex is described. | 2015-06-04 |
| 20150152030 | Method for production of CO, H2 and methanol-synthesis gas from a synthesis gas, in particular from acetylene off-gas - The invention relates to a method for production of a methanol-synthesis gas product stream ( | 2015-06-04 |
| 20150152031 | METHODS FOR PRODUCING BIODERIVED PROPYLENE GLYCOL - In the process of distilling a polyol product mixture including one or both of a biobased propylene glycol and a biobased ethylene glycol from the reaction of hydrogen with a biobased feed, it has been discovered that undesirable epoxides can form, and the present invention provides means for guarding against their formation, for removing epoxides which do form by particular methods of distilling, and for removing the epoxides from a finished, otherwise commercially acceptable biobased glycol product. | 2015-06-04 |
| 20150152032 | BUTANOL RECOVERY PROCESS - The present invention provides an improved process for recovering butanol from a mixture comprising water, methanol, propanol, butanol and optionally other organic compounds. More particularly, the invention relates to a process for recovering butanol as an essentially pure product from a mixture comprising water, methanol, propanol, butanol and other organic compounds. | 2015-06-04 |
| 20150152033 | Methods To Recover Cesium Formate From A Mixed Alkali Metal Formate Blend - Methods to recover or separate cesium formate or rubidium formate or both from a mixed alkali metal formate blend are described. One method involves adding cesium sulfate or rubidium sulfate to the mixed alkali metal formate blend in order to preferentially precipitate potassium sulfate from the mixed alkali metal formate blend. Another method involves adding cesium carbonate or cesium bicarbonate or both to preferentially precipitate potassium carbonate/bicarbonate and/or other non-cesium or non-rubidium metals from the mixed alkali metal blend. Further optional steps are also described. Still one other method involves converting cesium sulfate to cesium hydroxide. | 2015-06-04 |
| 20150152034 | Pharmaceutically Acceptable Salts of Fatty Acids - The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same. | 2015-06-04 |
| 20150152035 | COSMETIC USE OF SALICYLIC ACID DERIVATIVES - Cosmetic compositions comprising salicylic acid derivatives and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The salicylic acid derivatives are believed to have modulatory activity against one or more biochemical pathways implicated in the appearance of human skin. | 2015-06-04 |
| 20150152036 | METHOD OF PREPARING ESTER COMPOUND AND ESTER COMPOUND PREPARED THEREBY - This invention relates to a method of preparing an ester compound, including adding carboxylic acid to a mixture of glycerol and acetone in the presence of a sulfuric acid catalyst and applying an ultrasonic wave to induce an esterification reaction, and to an ester compound prepared thereby. | 2015-06-04 |
| 20150152037 | METHOD FOR PRODUCING CARBONATE COMPOUND AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE - The present invention relates to a method for producing a carbonate compound containing: a first step of reacting a compound represented by the following Formula (1) with a compound represented by the following Formula (21) or a compound represented by the following Formula (22) to obtain a reaction mixture containing a carbonate compound, and a second step of bringing the reaction mixture containing a carbonate compound into contact with a strongly basic compound, | 2015-06-04 |
| 20150152038 | CONTROL AND REPELLENCY OF BED BUGS - Control or repellency of bed bugs is accomplished by bringing the bed bugs into contact with at least one of the compounds of the structure (I); wherein R is selected from —OH, —OC(O)R | 2015-06-04 |
| 20150152039 | NORBORNENE-ESTER-BASED DERIVATIVE, METHOD FOR PREPARING SAME, AND USES THEREOF - The present invention relates to norbornene-ester-based derivatives, to a method for preparing same, and to the uses thereof. This compound may be used as a plasticizer which can replace a phthalate-based plasticizer. | 2015-06-04 |
| 20150152040 | Method For The Preparation Of Cinacalcet And Intermediates And Impurities Thereof - A method for the preparation of Cinacalcet is disclosed comprising treating (R)-1-naphthyl ethylamine with an aromatic aldehyde to form (1R)-1-(2-naphthyl)-N-(aryl methylene)ethanamine derivative of Formula (IV), which is further treated with 1-(3-halopropyl)-3-(trifluoromethyl)benzene of Formula (V) to obtain an iminium salt of Formula (VI), followed by hydrolysis to obtain Cinacalcet free base. | 2015-06-04 |
| 20150152041 | FBXO3 INHIBITORS - A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: | 2015-06-04 |
| 20150152042 | SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY - Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorders, premenstrual dysphoric disorder, social phobia, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, drug dependence, attention deficit hyperactivity disorder, fibromyalgia, irritable bowel syndrome, and/or premature ejaculation are described. | 2015-06-04 |
| 20150152043 | SYNTHESIS OF AND COMPOSITIONS CONTAINING DIAMINOACETALS AND DIAMINOKETALS - The present invention relates to the reduction of polycyano compounds to produce polyamines, in particular diaminoacetal and diaminoketal compounds, and their use as curing agents in epoxy resin compositions. The reduction with molecular hydrogen can be carried out using a metal catalyst selected from GROUP VIII and a catalytic promoter. The reduction can include anhydrous or aqueous ammonia. The reaction can be carried out in continuous and batch modes with catalyst and solvent recycling. The epoxy resin composition consisting of an epoxy resin and a polyamine curing agent that can be used in fiber-reinforced composite materials, coating materials, and the like. | 2015-06-04 |
| 20150152044 | DESFESOTERODINE SALTS - The invention relates to substantially pure Desfesoterodine salts, Desfesoterodine salts, solid state forms thereof and pharmaceutical compositions comprising one or more of the Desfesoterodine salts and/or solid state forms thereof. | 2015-06-04 |
| 20150152045 | REACTIVE IONIC LIQUIDS - The invention relates to reactive ionic liquids containing organic cations with groups or substituents which are susceptible to electrochemical reduction and anions obtained from fluoroalkyl phosphates, fluoroalkyl phosphinates, fluoroalkyl phosphonates, acetates, triflates, imides, methides, borates, phosphates and/or aluminates, for use in electrochemical cells, such as lithium ion batteries and double-layer capacitors. | 2015-06-04 |
| 20150152046 | IMINO COMPOUNDS AS PROTECTING AGENTS AGAINTS ULTRAVIOLET RADIATIONS - The present invention relates to compounds having the general Formula I: which absorb UV radiations and protect biological materials as well as non-biological materials from damaging exposure to UV radiations. The present invention also relates to formulations and compositions comprising such compounds for use in absorbing UV radiations and in protecting biological materials as well as non-biological materials against UV radiations. | 2015-06-04 |
| 20150152047 | BENZAMIDE DERIVATIVE - The present invention relates to benzamide derivatives represented by formula (I) or pharmaceutically acceptable salts thereof. | 2015-06-04 |
| 20150152048 | SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES - The present invention provides compounds of the general formula (I), their salts and N-oxides, and solvates and prodrugs thereof (wherein the substituents are as defined in the description). The compounds of the general formula (I) are inhibitors of factor XIa, and are useful in the prevention of and/or therapy for thromboembolic diseases. | 2015-06-04 |
| 20150152049 | Materials And Methods Useful To Induce Vacuolization, Cell Death, Or A Combination Thereof - The present invention provides materials and methods to induce cell death by methuosis, a non-apoptotic cell death mechanism, to induce vacuolization without cell death, or to induce cell death without vacuolization. Small molecules herein are useful for treating cell proliferation disorders or anomalies, particularly, but not exclusively, cancer. Methods related to the research and pharmaceutical use of the small molecules are also provided herein. | 2015-06-04 |
| 20150152050 | N-[3-(2-CARBOXYETHYL)PHENYL]PIPERIDIN-1-YLACETAMIDE DERIVATIVES AND USE THEREOF AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE - The present application relates to novel substituted 2-(piperidin-1-yl)acetamide derivatives, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of cardiovascular diseases. | 2015-06-04 |
| 20150152051 | PHARMACEUTICAL COMPOSITION OF A PAPILLOMAVIRUS INHIBITOR - The invention relates to a pharmaceutical composition including a compound of general formula (I) combined with a solvent and a viscosity-enhancing agent, as well as to the use thereof as a drug, in particular for treating and preventing infection with the papillomavirus, and to the method for preparing same. | 2015-06-04 |
| 20150152052 | AROMATIC RING COMPOUND - Provided is an aromatic ring compound having a glucagon antagonistic action, which is useful for the prophylaxis or treatment of diabetes and the like. A compound represented by the formula (I): | 2015-06-04 |
| 20150152053 | NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES - Polymerization inhibitor compositions are provided. The polymerization inhibitor compositions may include at least one hydroxylamine of a nitroxide and at least one phenylenediamine. Methods of inhibiting the unwanted polymerization of monomers are also provided. The methods include adding the presently disclosed polymerization inhibitor compositions to a fluid containing the monomers. The monomers may be ethylenically unsaturated monomers, such as acrylic acid, methacrylic acid, acrylonitrile, methacrylonitrile, acrolein, methacrolein, acrylate, methacrylate, acrylamide, methacrylamide, vinyl acetate, butadiene, ethylene, propylene, and styrene. | 2015-06-04 |
| 20150152054 | CRYSTALLINE FORMS OF A BIPHENYL COMPOUND - The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The crystalline form can be a freebase, or a salt such as a diphosphate, monosulfate or dioxalate salt. The invention also provides pharmaceutical compositions comprising these crystalline compounds or prepared using these compounds; processes and intermediates for preparing the crystalline compounds; and methods of using these compounds to treat a pulmonary disorder. | 2015-06-04 |
| 20150152055 | PROCESS FOR PREPARING DIHALOPYRIDINES - Processes for manufacturing dihalopyridines without the use of copper salts are described. Additional processes for manufacturing dihalopyridines from niacinamide are described. | 2015-06-04 |
| 20150152056 | Curcumin Analogs and Methods of Making and Using Thereof - Compounds having Formula I or II, and methods of making and using thereof, are described herein: | 2015-06-04 |
| 20150152057 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGIC DISEASES - The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of neurologic diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of epilepsy, migraine, neuropathic pain, post herpetic neuralgia, pain, Creutzfeld-Jakob disease, Alzheimer's disease, multiple sclerosis, Batten disease, multiple sclerosis, Parkinson's disease (PD), restless legs syndrome (RLS), cluster headache, depression, fibromyalgia, sexual dysfunction, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, autism, bipolar disorder and anxiety disorder, trigeminal neuralgia, attention-deficit hyperactivity disorder, schizophrenia, neuropathic pain, seizures, bipolar disorder and mania. | 2015-06-04 |
| 20150152058 | 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS - This invention relates to novel 3-aminopyridines of the formula | 2015-06-04 |
| 20150152059 | SOLID STATE FORMS OF N-((S)-2,3-DIHYDROXY-PROPYL)-3-(2-FLUORO-4-IODO-PHENYLAMINO)-ISONICOTINAM- IDE - The invention relates to solid state forms of N—((S)-2,3-Dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide, processes for their preparation, and medical uses thereof. | 2015-06-04 |
| 20150152060 | COMPOSITIONS AND METHODS FOR THE TREATMENT MIGRAINE AND NEUROLOGIC DISEASES - The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of migraine and neurologic diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of epilepsy, migraine, Post Herpetic Neuralgia, Acute and Chronic Pain, Alzheimer's disease, Creutzfeld Disease, familial amyloid polyneuropathy, parkinson's disease, fibromyalgia syndrome. | 2015-06-04 |
| 20150152061 | Method of Preparation of Pitavastatin and Pharmaceutical Acceptable Salts Thereof - The present invention discloses a compound, which is alkali or alkaline earth metal salts of pitavastatin, wherein the alkali or earth metal comprise one or more of magnesium, zinc, potassium, strontium and barium. | 2015-06-04 |
| 20150152062 | PROCESS FOR THE PREPARATION OF 5-FLUORO-1H-PYRAZOLES - A new process for the preparation of 5-fluoro-1H-pyrazoles of the general formula (I) | 2015-06-04 |
| 20150152063 | INDAZOLE GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF - The invention provides indazole guanidine compounds that inhibit F | 2015-06-04 |
| 20150152064 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like. | 2015-06-04 |
| 20150152065 | TNF -Alpha Modulating Benzimidazoles - A series of benzimidazole derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. | 2015-06-04 |
| 20150152066 | BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF IN CANCER THERAPY - The present invention relates to bendamustine derivatives and related compounds of formula (VII), (VIII) and (IX), and medical uses thereof in particular in cancer therapy. | 2015-06-04 |
| 20150152067 | PROCESS FOR MAKING HYDROXYLATED CYCLOPENTYLPYRIMIDINE COMPOUNDS - The invention provides processes for preparing a compound of formula I and salts thereof, wherein R | 2015-06-04 |
| 20150152068 | NOVEL AMINO PYRIMIDINE DERIVATIVES - The present invention describes new amino pyrimidine derivatives and pharmaceutically acceptable salts thereof which appear to interact with Bruton's tyrosine kinase (Btk). Accordingly, the novel amino pyrimidines may be effective in the treatment of autoimmune disorders, inflammatory diseases, allergic diseases, airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), transplant rejection, cancers e.g. of hematopoietic origin or solid tumors. | 2015-06-04 |
| 20150152069 | N2,N4-BIS(4-(PIPERAZINE-1-YL)PHENYL)PIRIMIDINE-2,4-DIAMINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER - Disclosed herein are a new N2,N4-bis(4-(piperazin-1-yl)phenyl)pyrimidin-2,4-diamine derivative or a pharmaceutically acceptable salt thereof and a pharmaceutical composition for the prevention or treatment of cancers containing the same as an active ingredient. The compound of the present invention has excellent inhibitory effects against the activities of anaplastic lymphoma kinase (ALK) and activated cdc42-associated kinase (ACK1) and thus can improve the therapeutic effects on the treatment of cancer cells having anaplastic lymphoma kinase fusion proteins such as EML4-ALK and NPM-ALK, and also effectively prevent the recurrence of cancers thus being useful as a pharmaceutical composition for the prevention and treatment of cancers. | 2015-06-04 |
| 20150152070 | METHODS OF PEST CONTROL IN SOYBEAN - The invention provides methods comprising applying to a crop of soybean plants, the locus thereof, or propagation material thereof, a compound of formula (I) wherein —B | 2015-06-04 |
| 20150152071 | C17-HETEROARYL DERIVATIVES OF OLEANOLIC ACID AND METHODS OF USE THEREOF - Disclosed herein are novel C17-heteroaryl derivatives of oleanolic acid, including those of the formula: | 2015-06-04 |
| 20150152072 | Method For Preparing Methylated Amines - The present invention relates to a method for preparing methylated amines using carbon dioxide and to the use of the method for manufacturing vitamins, pharmaceutical products, glues, acrylic fibres and synthetic leathers, pesticides and fertilizers. The invention also relates to a method for manufacturing vitamins, pharmaceutical products, glues, acrylic fibres, synthetic leathers, pesticides and fertilizers, including a step of preparing methylated amines by the method according to the invention. The present invention also relates to a method for preparing marked methylated amines and to the uses thereof. | 2015-06-04 |
| 20150152073 | Hepatitis B Antiviral Agents - The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention. | 2015-06-04 |
| 20150152074 | PROCESS FOR THE PRODUCTION OF FURFURAL - Furfural is produced by contacting a feedstock solution containing C | 2015-06-04 |
| 20150152075 | NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS - A compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney is disclosed. A pharmaceutical composition including the compound as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes is disclosed. A method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound is provided. | 2015-06-04 |
| 20150152076 | Geranyl Geranyl Acetone Analogs and Uses Thereof - The invention relates to novel therapeutic compounds, more in particular to biologically active analogs and uses thereof as medicament, for instance for the treatment of atrial fibrillation. Provided is a compound of the general formula (formula I) wherein R | 2015-06-04 |
| 20150152077 | SecA Inhibitors and Methods of Making and Using Thereof - Inhibitors of SecA, and methods of making and using thereof, are described herein. The compounds described herein can be used to treat or prevent microbial infections, such as bacterial infections. | 2015-06-04 |
| 20150152078 | HYDROGENATION OF CATMINT OIL - Disclosed are methods for treating catmint oil. The treated catmint oil can be used for the production of hydrogenated catmint oil, which is enriched in the insect repellent, dihydronepetalactone. | 2015-06-04 |
| 20150152079 | Method for producing polyglycerol (poly)carbonate - The invention relates to a method for producing a compound of fonnula (I), comprising the reaction, in the presence of a catalytic system comprising a single rare earth oxide or a mixture of rare earth oxides, of an alkyl carbonate or an alkylene carbonate with a polyol of fonnula (II), wherein p is a whole number between 2 and 10. | 2015-06-04 |
| 20150152080 | BENZOTHIOPHENE SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS - The present invention relates to benzothiophene sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors. | 2015-06-04 |
| 20150152081 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE PAIN - The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of severe pain may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of chronic pain, generalized pain disorders, leukemia, cancer, chronic pain, chemotherapy induced pain, epilepsy, migraine, neuropathic pain, post herpetic neuralgia, neuralgia, pain, drug addiction, detoxification of drugs, Alzheimer's disease, multiple sclerosis, multiple sclerosis, restless legs syndrome (RLS), cluster headache, depression, fibromyalgia, amyotrophic lateral sclerosis (ALS), convulsions, partial seizures, mood-stabilizing agent and bipolar disorder. | 2015-06-04 |
| 20150152082 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND - The present invention provides an industrially advantageous method for producing an optically active naphthalene compound useful as a therapeutic agent for dermatitis or the like. Specifically, the present invention provides a method for producing an optically active naphthalene compound [I], which comprises: a step of reacting a compound [a-1] and a compound [b-1] with each other in the presence of a base and a catalyst that is composed of a Pd compound and a tertiary phosphine ligand (step a); a step of asymmetrically hydrogenating a compound [c-1] in the presence of a hydrogen donor and a complex that is prepared from a ruthenium compound and a chiral ligand, or alternatively in the presence of an optically active oxazaborolidine compound (a CBS catalyst) and a boron hydride compound (step b); and a step of treating a compound [d-1] with a reducing agent (step c). (In the above formulae, R | 2015-06-04 |
| 20150152083 | Compounds and Compositions for Modulating EGFR Activity - The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating EGFR activity, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated EGFR activity. | 2015-06-04 |
| 20150152084 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR MILD COGNITIVE IMPAIRMENT - Provided is a prophylactic and/or therapeutic drug for mild cognitive impairment, which can improve interstitial flow in cerebral blood vessel and the like to achieve sufficient clearance of harmful proteins accumulated in the brain. The prophylactic and/or therapeutic drug includes 6-[4-(1-cyclohexyl-1H-tetrazole-5-yl)butoxy]3,4-dihydrocarbostyril or a salt thereof as an active ingredient. The prophylactic and/or therapeutic drug can improve a flow of interstitial fluid around blood vessels in a drainage pathway to excrete harmful proteins. The prophylactic and/or therapeutic drug for mild cognitive impairment may take the form of a pharmaceutical product for oral administration, a liquid pharmaceutical product for oral administration, or an injectable preparation. The prophylactic and/or therapeutic drug for mild cognitive impairment can be used for the prevention and/or treatment of cerebral amyloid angiopathy, and can also be used for improvement of Lewy body disease, Down's syndrome, or macular degeneration. | 2015-06-04 |
| 20150152085 | PHENYL TRIAZOLE DERIVATIVE AND ITS USE FOR MODULATING THE GABAA RECEPTOR COMPLEX - This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABA | 2015-06-04 |
| 20150152086 | Insecticidal Aryl Pyrrolidines - The present invention provides novel aryl pyrrolidines having an excellent insecticidal action as insecticides. Aryl pyrrolidines represented by the formula (I) and use thereof as insecticide. | 2015-06-04 |
| 20150152087 | Monocyclic Heteroaryl Cycloalkyldiamine Derivatives - The present invention relates to monocyclic heteroaryl cycloalkyldiamine derivatives of formula (I), to processes for their production, to their use as pharmaceuticals and to pharmaceutical compositions comprising them. | 2015-06-04 |
| 20150152088 | ALKYNYL HETEROAROMATIC COMPOUND AND USE THEREOF - The present invention belongs to the field of pharmaceutical chemistry, and specifically relates to compounds having an alkynyl heteroaromatic ring structure and pharmaceutically acceptable salts, stereoisomers, N-oxides, solvates, or prodrugs thereof, and pharmaceutical compositions comprising these compounds, as well as uses of these compounds and compositions in the manufacture of a medicament. The compounds of the present invention and the pharmaceutically acceptable salts, stereoisomers, N-oxides, solvates or prodrugs thereof and the pharmaceutical compositions comprising the compounds have better anti-tumor activity. | 2015-06-04 |
| 20150152089 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION - The present disclosure provides a series of compounds of the formula (I) | 2015-06-04 |
